|Awarded On||August 16, 2023|
|Title||The acquisition of an instrument suite to set up a high-throughput screening core at Texas A&M University|
|Award Mechanism||TREC: Major Instrumentation Award|
|Institution/Organization||Texas A&M University|
|Principal Investigator/Program Director||Wenshe Liu|
|Cancer Sites||All Sites|
*Pending contract negotiation
Cancer is a significant public health challenge affecting millions of people and placing a considerable burden on the healthcare system. Despite the tremendous advances made in cancer research, many types of cancer remain untreatable, and there is a continuous and urgent need for cancer therapeutics. High-throughput screening of small molecules is an effective drug discovery approach used for the identification of hit compounds and their optimization for improved characteristics. However, readily accessible high-throughput instrument suites in academic settings are not common. Texas A&M University is one such institution that lacks an openly accessible high-throughput screening facility for ...